3 Specialty Chemicals Maker, Artificial Leather Maker and Generics and Active Ingredients Company Stocks With a Strong Future Roadmap: Clean Science and Technology, Mayur Uniquoters and Dr. Reddy's Laboratories

Specialty chemical, leather and generic stocks give investors a way to track businesses that sit close to everyday demand in India. Clean Science and Technology, Mayur Uniquoters and Dr. Reddy's Laboratories cover a specialty chemicals maker, an artificial leather maker and a generics and active ingredients company.

This list covers three specialty chemical, leather and generic stocks with complete current figures: Clean Science and Technology, Mayur Uniquoters and Dr. Reddy's Laboratories. Every figure comes from the latest reported financials and the 30 October 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

What Are Specialty Chemical, Leather and Generic Stocks?

Specialty chemical, leather and generic stocks are listed companies that make performance chemicals and pharma intermediates, produce artificial leather and synthetic fabrics for footwear and autos, and make generics and active ingredients for global markets. Their earnings depend on export orders, product mix and input costs.

Specialty Chemical, Leather and Generic Stocks at a Glance

On valuation, all three trade at a P/E below their industry P/E, which means the market is pricing them at a lower multiple than their peer group. Readers comparing specialty chemical, leather and generic stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.

Why Do Specialty Chemical, Leather and Generic Stocks Have a Strong Roadmap in India?

Specialty chemical, leather and generic stocks have a strong roadmap in India because niche chemistry leadership, wider use of synthetic leather and steady generic demand keep widening the market for these export focused makers.

• Niche chemistry. Leading products support pricing strength.
• Synthetic leather. Footwear and autos use synthetic fabrics.
• Generic demand. Global buyers need affordable medicines.

Why Clean Science and Technology Features Among These Specialty Chemical, Leather and Generic Stocks

Among the specialty chemical, leather and generic stocks on this list, Clean Science and Technology makes specialty chemicals including performance chemicals, pharma intermediates and FMCG chemicals using its own catalytic processes.

In the June 2026 quarter, revenue grew 13.4% year on year to Rs 291 crore, while net profit rose 4.7% to Rs 73.3 crore. Revenue rose from Rs 715 crore in FY22 to Rs 989 crore in FY26, a compound annual growth rate of 8.5%.

Net profit for FY26 was Rs 230 crore, a net margin of 23.2%. The company has a return on equity of 14.5%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 8,080 crore. The stock trades at a P/E of 34.7, below the industry P/E of 35.1.

Roadmap: The company uses cleaner, in-house developed processes that give it cost advantages in products such as MEHQ and guaiacol. It is adding new products and capacity, and carries no debt.

What to watch: Watch new product launches and capacity utilisation at its newer plants.

Why Mayur Uniquoters Features Among These Specialty Chemical, Leather and Generic Stocks

Among the export oriented shares on this list, Mayur Uniquoters is a Rajasthan-based maker of artificial leather and synthetic fabrics used in footwear, automotive upholstery, furniture and other applications.

The company has a return on equity of 16.9%, a debt to equity ratio of 0.01 and a market capitalisation of Rs 3,260 crore. The stock trades at a P/E of 15.7, below the industry P/E of 37.9.

Revenue rose from Rs 677 crore in FY22 to Rs 1,022 crore in FY26, a compound annual growth rate of 10.9%. Net profit grew from Rs 94.4 crore in FY22 to Rs 192 crore in FY26, which works out to a compound annual growth rate of 19.4%. In the June 2026 quarter, revenue grew 24.1% year on year to Rs 292 crore, while net profit rose 37.8% to Rs 56.1 crore.

Roadmap: The company supplies automotive and footwear customers in India and overseas, and demand for synthetic leather is growing as it replaces genuine leather. A debt-free balance sheet allows it to invest in new products and capacity.

What to watch: Check the volume trend in automotive and footwear customers and export sales.

Why Dr. Reddy's Laboratories Features Among These Specialty Chemical, Leather and Generic Stocks

Among the three companies on this list, Dr. Reddy's Laboratories is a Hyderabad-based pharmaceutical company that makes generics, active ingredients and branded products for India and global markets, with a large presence in North America and Europe.

Revenue rose from Rs 22,030 crore in FY22 to Rs 35,059 crore in FY26, a compound annual growth rate of 12.3%. Net profit grew from Rs 2,182 crore in FY22 to Rs 4,158 crore in FY26, which works out to a compound annual growth rate of 17.5%.

The company has a return on equity of 11.1%, a debt to equity ratio of 0.20 and a market capitalisation of Rs 103,667 crore. The stock trades at a P/E of 32.6, below the industry P/E of 36.0.

Roadmap: The company is widening its product pipeline with complex generics, biosimilars and consumer health, while its domestic business adds steady growth. Investment in research supports a stream of new launches.

What to watch: Monitor launches of complex generics and the progress of biosimilar programmes.

Clean Science and Technology vs Mayur Uniquoters vs Dr. Reddy's Laboratories on Key Financials

The table below sets the three specialty chemical, leather and generic stocks side by side on revenue, profit and margin, using reported figures.

Mayur Uniquoters posts the highest return on equity in this group at 16.9%. Dr. Reddy's Laboratories combines the largest FY26 revenue at Rs 35,059 crore with the fastest revenue growth, a 12.3% compound annual rate. A useful habit with specialty chemical, leather and generic stocks is to check each new quarterly result against the capacity plans the company described earlier.

Key Risks to Check Before Investing in Specialty Chemical, Leather and Generic Stocks

Every theme carries risks that deserve a check before any decision. For these specialty chemical, leather and generic stocks, the main points are: Long-term export oriented shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.

• Currency moves. Export earnings move with the rupee.
• Raw material and energy costs. Input prices can move margins in chemicals.
• Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them.

Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.

Use the Univest Stock Screener to filter specialty chemical, leather and generic stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.

Final Thoughts on Specialty Chemical, Leather and Generic Stocks

Specialty chemical, leather and generic stocks work best when investors track growth, valuation and return on equity side by side. Clean Science and Technology, Mayur Uniquoters and Dr. Reddy's Laboratories each have a clear plan to grow. Based on the 30 October 2026 close, Clean Science and Technology trades at Rs 715.6, Mayur Uniquoters at Rs 715.45 and Dr. Reddy's Laboratories at Rs 1,352. Valuation matters as much as growth, so compare each company's P/E with its industry P/E before adding any of these specialty chemical, leather and generic stocks to a watchlist.

Download the Univest iOS App or Univest Android App to track specialty chemical, leather and generic stocks, set price alerts and get research-backed stock ideas.

What are specialty chemical, leather and generic stocks?

Ans. Specialty chemical, leather and generic stocks are listed companies that make performance chemicals and pharma intermediates, produce artificial leather and synthetic fabrics for footwear and autos, and make generics and active ingredients for global markets. Their earnings depend on export orders, product mix and input costs. This list looks at three of them, Clean Science and Technology, Mayur Uniquoters and Dr. Reddy's Laboratories, using reported FY22 to FY26 financials and the 30 October 2026 closing prices.

Which specialty chemical, leather and generic stocks are covered in this list?

Ans. This list covers Clean Science and Technology, Mayur Uniquoters and Dr. Reddy's Laboratories. Based on the 30 October 2026 close, Clean Science and Technology traded at Rs 715.6, Mayur Uniquoters at Rs 715.45 and Dr. Reddy's Laboratories at Rs 1,352. Their return on equity ranges from 11.1% to 16.9%, and their revenue compound annual growth from FY22 to FY26 ranges from 8.5% to 12.3%.

Why do specialty chemical, leather and generic stocks have a strong future roadmap in India?

Ans. Specialty chemical, leather and generic stocks have a strong roadmap in India because niche chemistry leadership, wider use of synthetic leather and steady generic demand keep widening the market for these export focused makers. The main drivers are as follows. Niche chemistry. Leading products support pricing strength. Synthetic leather. Footwear and autos use synthetic fabrics. Generic demand. Global buyers need affordable medicines. Together these factors give the companies on this list a visible path for growth over the coming years.

How has Clean Science and Technology performed financially?

Ans. Revenue rose from Rs 715 crore in FY22 to Rs 989 crore in FY26, a compound annual growth rate of 8.5%. Net profit for FY26 was Rs 230 crore, a net margin of 23.2%. In the June 2026 quarter, revenue grew 13.4% year on year to Rs 291 crore, while net profit rose 4.7% to Rs 73.3 crore. The company has a return on equity of 14.5%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 8,080 crore. The stock trades at a P/E of 34.7, below the industry P/E of 35.1. Looking ahead, the company uses cleaner, in-house developed processes that give it cost advantages in products such as MEHQ and guaiacol. It is adding new products and capacity, and carries no debt.

How has Mayur Uniquoters performed financially?

Ans. Revenue rose from Rs 677 crore in FY22 to Rs 1,022 crore in FY26, a compound annual growth rate of 10.9%. Net profit grew from Rs 94.4 crore in FY22 to Rs 192 crore in FY26, which works out to a compound annual growth rate of 19.4%. In the June 2026 quarter, revenue grew 24.1% year on year to Rs 292 crore, while net profit rose 37.8% to Rs 56.1 crore. The company has a return on equity of 16.9%, a debt to equity ratio of 0.01 and a market capitalisation of Rs 3,260 crore. The stock trades at a P/E of 15.7, below the industry P/E of 37.9. Looking ahead, the company supplies automotive and footwear customers in India and overseas, and demand for synthetic leather is growing as it replaces genuine leather. A debt-free balance sheet allows it to invest in new products and capacity.

How has Dr. Reddy's Laboratories performed financially?

Ans. Revenue rose from Rs 22,030 crore in FY22 to Rs 35,059 crore in FY26, a compound annual growth rate of 12.3%. Net profit grew from Rs 2,182 crore in FY22 to Rs 4,158 crore in FY26, which works out to a compound annual growth rate of 17.5%. The company has a return on equity of 11.1%, a debt to equity ratio of 0.20 and a market capitalisation of Rs 103,667 crore. The stock trades at a P/E of 32.6, below the industry P/E of 36.0. Looking ahead, the company is widening its product pipeline with complex generics, biosimilars and consumer health, while its domestic business adds steady growth. Investment in research supports a stream of new launches.

What risks should investors check before buying specialty chemical, leather and generic stocks?

Ans. Investors should check a few risks before buying specialty chemical, leather and generic stocks. Currency moves. Export earnings move with the rupee. Raw material and energy costs. Input prices can move margins in chemicals. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.

Is this list of specialty chemical, leather and generic stocks investment advice?

Ans. No. This article is educational and uses publicly available data as of the 30 October 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.